Tag | Content |
---|
EnhancerAtlas ID | HS072-01099 |
Organism | Homo sapiens |
Tissue/cell | GM19193 |
Coordinate | chr19:36192920-36193820 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_59463 | chr19:36184851-36210443 | Ly3 | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | CGCCCGGCTA ATTTTTGTAT TTTTAGTAGA GACGGGGTTT CACCATATTG GTCAGGCTGG 60 TCTCGAACTC CTGACCTCAG GTGATCTGCC CGCCTTAGCC TCCCAAAGTG CTGGGATTAC 120 AGGCGTGAGC CACCACGTCC GGCCCCTTCC CCCATTTTAG CGGTTTCGCT CCCTATCGGG 180 GCCAGGGACG CCTCAGGCTG TCTCGGTCAG GACCTACAGC TCCGGTTGTT GTCCCAGGCT 240 CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC CACCCCCATT CCTCCCCACT CCAGCTCCTC 300 AGCGAGCGGC TGCGAAGGAC GCGCACAACA ACACTCCGCG CAGCGGGAAG GTACCGAACT 360 CGCATCGCAG CCTGAAACTG CTCAACTAAG CTCCCGCCCC GCTGCTCTCT GGTCAATCTA 420 AAGCGAAGAC GAGCCTTAGG GCCAATCAGA AGCGACAGCG GTGGAGTCAT GCCCGCCTGC 480 TTGAGGCGCC CTGGCGTCTC ATTGGCTATG CTTGAGAACG AATCCCAGGC TAAGCCACTT 540 AGAAAGGAGC GGAGCCAGCC AATCAGCGGT GCAACCGCCG CGGGGGCCGG GCCAGAAGCC 600 CCGCAGACAA GCACCTCGGG AGACTGGCGA GGGGCGAGCT CGCAGCTTGT TAGCCCCGAA 660 GCCCTGCCCA GGGGGAAACC CTGCTGGAGG GAGTCTAACC CCCGGGCCAG TTAATGTTGG 720 GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT ATGGTTGGAG GTGGGAGTGC TGACACGTCC 780 GCGCGCAGTT ACTCCTGGCT GAGCATACAG TCGAGGTGGC AGTGGGAATT GGAAGTGCAA 840 GTGTCACGCT GCCAATCACG GGGCAAGGCA CTGCCCCCCT CTTGTGTCTT TCCTGTCCCT 900
|